These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38607760)

  • 61. Quantitative electromyography in ambulatory boys with Duchenne muscular dystrophy.
    Verma S; Lin J; Travers C; McCracken C; Shah D
    Muscle Nerve; 2017 Dec; 56(6):1168-1171. PubMed ID: 28457006
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationships between muscle size, strength, and physical activity in adults with muscular dystrophy.
    Jacques MF; Onambele-Pearson GL; Reeves ND; Stebbings GK; Smith J; Morse CI
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1042-1052. PubMed ID: 30338901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Electrocardiographic and Autonomic Nervous System Changes after Changes in the Posture of Children and Adolescents with Duchenne Muscular Dystrophy.
    Silva RMFLD; Monteze NM; Giannetti JG; Meira ZMA
    Arq Bras Cardiol; 2024; 121(2):e20230483. PubMed ID: 38597534
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A New Instrument to Assess Dynamic Balance in Children with Duchenne Muscular Dystrophy: Four Square Step Test and Its Validity, Reliability and Feasibility.
    Aldirmaz E; Uğur F; Yilmaz Ö; Karaduman A; Alemdaroğlu-Gürbüz İ
    Dev Neurorehabil; 2023 Jan; 26(1):27-36. PubMed ID: 36367327
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy.
    Arteaga D; Donnelly T; Crum K; Markham L; Killian M; Burnette WB; Soslow J; Buchowski MS
    J Neuromuscul Dis; 2020; 7(3):331-342. PubMed ID: 32417792
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ambulatory capacity in Japanese patients with Duchenne muscular dystrophy.
    Awano H; Itoh C; Takeshima Y; Lee T; Matsumoto M; Kida A; Kaise T; Suzuki T; Matsuo M
    Brain Dev; 2018 Jun; 40(6):465-472. PubMed ID: 29551259
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The assisted 6-minute cycling test to assess endurance in children with a neuromuscular disorder.
    Jansen M; De Jong M; Coes HM; Eggermont F; Van Alfen N; De Groot IJ
    Muscle Nerve; 2012 Oct; 46(4):520-30. PubMed ID: 22987692
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
    Smith EC; Conklin LS; Hoffman EP; Clemens PR; Mah JK; Finkel RS; Guglieri M; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; Kerchner L; Morgenroth LP; Arrieta A; Shimony M; Jaros M; Shale P; Gordish-Dressman H; Hagerty L; Dang UJ; Damsker JM; Schwartz BD; Mengle-Gaw LJ; McDonald CM;
    PLoS Med; 2020 Sep; 17(9):e1003222. PubMed ID: 32956407
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Defining ambulation status in patients with Duchenne muscular dystrophy using the 10-metre walk test and the motor function measure scale.
    Petian-Alonso DC; de Castro AC; Barroso de Queiroz Davoli G; Martinez EZ; Mattiello-Sverzut AC
    Disabil Rehabil; 2023 Sep; 45(18):2984-2988. PubMed ID: 35980858
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
    Mah JK; Clemens PR; Guglieri M; Smith EC; Finkel RS; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; McDonald CM; Damsker JM; Schwartz BD; Mengle-Gaw LJ; Jackowski S; Stimpson G; Ridout DA; Ayyar-Gupta V; Baranello G; Manzur AY; Muntoni F; Gordish-Dressman H; Leinonen M; Ward LM; Hoffman EP; Dang UJ;
    JAMA Netw Open; 2022 Jan; 5(1):e2144178. PubMed ID: 35076703
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Autonomic Modulation in Duchenne Muscular Dystrophy during a Computer Task: A Prospective Control Trial.
    Alvarez MP; Silva TD; Favero FM; Valenti VE; Raimundo RD; Vanderlei LC; Garner DM; Monteiro CB
    PLoS One; 2017; 12(1):e0169633. PubMed ID: 28118369
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy.
    McDonald CM; Widman LM; Walsh DD; Walsh SA; Abresch RT
    Arch Phys Med Rehabil; 2005 Apr; 86(4):802-8. PubMed ID: 15827935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of AFO use on walking in boys with Duchenne muscular dystrophy: a pilot study.
    Townsend EL; Tamhane H; Gross KD
    Pediatr Phys Ther; 2015; 27(1):24-9. PubMed ID: 25401456
    [TBL] [Abstract][Full Text] [Related]  

  • 74. European regulators' views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials.
    Haberkamp M; Moseley J; Athanasiou D; de Andres-Trelles F; Elferink A; Rosa MM; Magrelli A
    Neuromuscul Disord; 2019 Jul; 29(7):514-516. PubMed ID: 31272741
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Walking activity in a large cohort of boys with Duchenne muscular dystrophy.
    Lott DJ; Taivassalo T; Senesac CR; Willcocks RJ; Harrington AM; Zilke K; Cunkle H; Powers C; Finanger EL; Rooney WD; Tennekoon GI; Vandenborne K
    Muscle Nerve; 2021 Feb; 63(2):192-198. PubMed ID: 33188573
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration.
    Goemans N; Wong B; Van den Hauwe M; Signorovitch J; Sajeev G; Cox D; Landry J; Jenkins M; Dieye I; Yao Z; Hossain I; Ward SJ;
    PLoS One; 2020; 15(6):e0232870. PubMed ID: 32555695
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ambulatory electrocardiographic longitudinal monitoring in a canine model for Duchenne muscular dystrophy identifies decreased very low frequency power as a hallmark of impaired heart rate variability.
    Barthélémy I; Su JB; Cauchois X; Relaix F; Ghaleh B; Blot S
    Sci Rep; 2024 Apr; 14(1):8969. PubMed ID: 38637619
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis.
    Schmidt S; Hafner P; Klein A; Rubino-Nacht D; Gocheva V; Schroeder J; Naduvilekoot Devasia A; Zuesli S; Bernert G; Laugel V; Bloetzer C; Steinlin M; Capone A; Gloor M; Tobler P; Haas T; Bieri O; Zumbrunn T; Fischer D; Bonati U
    Neuromuscul Disord; 2018 Jan; 28(1):16-23. PubMed ID: 29174526
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Jumping Mechanography is a Suitable Complementary Method to Assess Motor Function in Ambulatory Boys with Duchenne Muscular Dystrophy.
    Blaschek A; Rodrigues M; Rawer R; Müller C; Ille L; Schröder S; Idriess M; Müller-Felber W; Vill K
    Neuropediatrics; 2021 Dec; 52(6):455-461. PubMed ID: 33706402
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration.
    Siemionow M; Biegański G; Niezgoda A; Wachowiak J; Czarnota J; Siemionow K; Ziemiecka A; Sikorska MH; Bożyk K; Heydemann A
    Stem Cell Rev Rep; 2023 Nov; 19(8):2724-2740. PubMed ID: 37707670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.